Pancreatic cancer has an extremely poor prognosis, due, in part, to lack of methods for early diagnosis. The present study was designed to evaluate the potential of labeling low-density lipoprotein (LDL) with a radionuclide using a lipid chelating agent, bis(stearylamide) of diethylenetriaminepentaacetic acid (L), to detect pancreatic tumors by gamma-scintigraphy. Previous studies indicated that the difficulty of visualization of pancreatic tumors was due to their poor vascularization. This study compares the ability of two radiotracers, 111 In-L-LDL and 153 Gd-L-LDL to target highly vascularized rat pancreatic tumors (AR4-2J) implanted in nude mice. Biodistribution studies showed that the tumor uptake of 111 In-L-LDL and 153 Gd-L-LDL tracers was twofold and fivefold higher respectively than with the controls ( 111 In citrate and 153 Gd citrate respectively). These tracers would thus be suitable for scintigraphic imaging.We show here that LDL could be employed as a delivery system for tracers such as 111 In or 153 Gd when these two radionuclides are complexed by a lipid-chelating anchor, and that 111 In-L-LDL and 153 Gd-L-LDL enabled better visualization of the pancreatic tumor tissues, with a better result with 153 Gd-L-LDL.